Log In
Print
BCIQ
Print
Print this Print this
 

SHP610 (formerly HGT1410)

Also known as: formerly HGT-1410

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant human N-sulfoglucosamine sulfohydrolase (SGSH; HNS)
Molecular Target N-sulfoglucosamine sulfohydrolase (SGSH) (HNS)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationMucopolysaccharidosis
Indication DetailsTreat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome)
Regulatory Designation

U.S. - Orphan Drug (Treat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome));
EU - Orphan Drug (Treat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today